Sprecher
Marieke van Dalen, Aspen Oss B.V., The Netherlands
Hiltrud Horn, Horn Pharmaceutical Consulting, Germany
Usfeya A Muazzam, Bonn, Germany
Wilhelm Schlumbohm, Berlin, Germany
Hiltrud Horn, Horn Pharmaceutical Consulting, Germany
Usfeya A Muazzam, Bonn, Germany
Wilhelm Schlumbohm, Berlin, Germany
Zielsetzung
This Live Online Training is intended to provide guidance on the procedures for the European ASMF, the US-DMF and the Japanese DMF.
You will get to know
- how to describe manufacturing processes
- how to compile data for drug substance stability, impurities and residual solvents
- which are the important points to consider for US-DMFs
- which are the requirements for Japanese DMFs
- how to handle changes in European, US- and Japanese DMFs
- which are the major differences and advantages of the ASMF and CEP procedure
Hintergrund
Documentation of the drug substance quality is an integral part of any marketing authorisation application. In Europe the most common document for this purpose is the Active Substance Master File (ASMF) as long as the applicant has no Certificate of Suitability of the pharmacopoeial monograph (CEP). The European ASMF procedure differs significantly from the US-DMF procedure and for strategic reasons it is very important to take these differences into account. Moreover there are particular requirements for DMFs in Japan. For global acting companies it is a big challenge to handle the different procedures of compiling, submitting, changing and maintaining Drug Master Files in an efficient way.
Zielgruppe
The Live Online Training is designed for all persons involved in the compilation of pharmaceutical dossiers for marketing authorisations especially for Drug Master Files who want to become familiar with the different DMF procedures. Furthermore, the course will be of interest to personnel from Quality Units of the pharmaceutical and the API industry.
Technical Requirements
For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.
At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.
Programm
Programme 29 September 2020
09.00 – 09.15 h Introduction
09.15 – 10.00 h
The European Active Substance Master File
09.00 – 09.15 h Introduction
09.15 – 10.00 h
The European Active Substance Master File
- Procedure – An Introduction
- Regulatory background and Scope
- The revised ASMF guideline
- Open and closed parts – points to consider
- Comparison of ASMF and CEP procedure
10.00 – 10.15 h
Q & A Session
10.15 – 10.45 h Break
10.45 – 11.30 h
Drug Master File Procedures in the US
Q & A Session
10.15 – 10.45 h Break
10.45 – 11.30 h
Drug Master File Procedures in the US
- Types of Drug Master Files
- Drug Master Files under GDUFA
- Submissions of DMFs
- Holder obligations
- Maintenance of Drug Master Files
- US vs EU DMF – differences in the procedure
11.30 – 11.45 h
Q & A Session
Q & A Session
11.45 – 12.30 h
Handling Changes in the EU
- Why is there a need for changes
- Types of changes
- How to communicate with the MA holders and how to get feed back
- Differences between ASMF and CEP
- When to implement a specific change
- Version management of the ASMF
12.30 – 12.45 h
Q & A Session
12.45 – 14.00 h Break
14.00 – 14.45 h
Post Approval Changes in the US
Q & A Session
12.45 – 14.00 h Break
14.00 – 14.45 h
Post Approval Changes in the US
- Post approval activities
- Reporting requirements to the FDA (CBE 0, CBE 30, Annual Report)
- Post approval commitments and post approval reporting requirements
- Risk evaluation and mitigation strategies (REMS)
14.45 – 15.00 h
Q & A Session
15.00 – 15.30 h Break
15.30 – 16.30 h
Description of the Active Substance Manufacturing Process
Q & A Session
15.00 – 15.30 h Break
15.30 – 16.30 h
Description of the Active Substance Manufacturing Process
- Regulatory basis - relevant guidelines
- Description of the Active Substance Manufacturing process
- Active substance starting material
- Critical steps in the synthesis
- Process validation
16.30 – 16.45 h
Q & A Session
Q & A Session
Programme 30 September 2020
08.30 – 09.15 h
Comparison of the CEP and ASMF Procedure
- The certification scheme of the Ph.Eur.
- Advantages and disadvantages of the CEP procedure compared to the ASMF procedure
- Handling of variations in the CEP procedure
- Countries accepting CEPs
09.15 – 09.30 h
Q & A Session
Q & A Session
09.30 – 10.15 h
How to document Drug Substance Stability
- Stability Guidelines
- Stability Testing of new drug substances and drug products
- Storage Conditions
- Bracketing and Matrixing Designs
- Stability data from new drug dosage forms
- How to document evaluation of stability data
- Optimising the submission
10.15 – 10.30 h
Q & A Session
Q & A Session
10.30 – 11.00 h Break
11.00 – 11.45 h
Residual Solvents and Impurities: Synthesis derived Impurities, Metals and genotoxic Impurities
- Guidelines
- Impact of the new guidelines ICH Q3D and ICH M7
- Sources of Impurities
- Setting and justification of specifications
- Residual solvents, solvent classes
- Content and scope of data – documentation requirements
- Frequent mistakes
11.45 – 12.00 h
Q & A Session
Q & A Session
12.00 – 13.00 h Break
13.00 – 14.15 h
Requirements of the Drug Master File Procedure in Japan (Part 1 and 2)
- Regulatory procedures in Japan:
- Site accreditation
- GMP paper-based inspection
- Drug Master File
- Drug Master File format
- Specific points to consider for the J-DMF
- Communication with the Japanese authorities
14.15 – 14.30 h
Q & A Session
Q & A Session
14.30 – 15.00 h Break
15.00 – 16.00 h
Workshop
Managing Changes in Drug Master Files – Case Studies
16.00 – 16.30 h
Final Q & A Session
Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Übersicht nach Thema..
Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in einer themensortierten Liste.
Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.
* auch unkompliziert per Kreditkarte bezahlbar
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
Weitere Termine online
Weitere Termine online nicht verfügbar
Aufzeichnung nicht verfügbar
Haben Sie noch Fragen?
Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
Tel.: +49 6221 84 44 0
E-Mail: info@concept-heidelberg.de
Teilnehmerstimmen - das sagen andere über unsere Seminare:
